Blood Typing Market Report: Market Size & Forecast 2026

The Blood Typing Market covers consumables such as reagents and kits, automated analyzers, and supporting software used by hospital blood banks, reference laboratories, and donation centers. The market is segmented by product (kits, instruments, software), by test method (serology, molecular/genotyping), and by end user, with hospitals and diagnostic laboratories accounting for the majority of demand. Forward forecasts suggest the market will roughly double over the next decade, reflecting both higher testing volumes and a shift toward higher-value molecular assays.

• •Global market valued at approximately USD 4.1 billion in 2025, growing at ~7.5% CAGR
• •Projected to reach USD 5.5-6.0 billion by 2033-2035 across major outlooks
• •Kits and reagents form the largest product segment, followed by instruments and software

Demand is being driven by the rising volume of surgical procedures, trauma care, and chronic disease management that require pre-transfusion compatibility testing. Expanding government-mandated prenatal and newborn screening programs, particularly in emerging economies, are adding millions of new tests annually. At the same time, the limitations of serological methods for rare antigen detection are accelerating adoption of molecular blood group genotyping.

• •Increasing surgical procedures and trauma cases boost pre-transfusion typing volumes
• •Mandatory prenatal and neonatal screening programs in developing markets add new test demand
• •Molecular genotyping is being adopted for rare antigens, sickle cell disease, and chronically transfused patients

By method, serological testing remains the dominant technique due to its low cost and entrenched use in routine ABO/Rh typing, while molecular assays are the fastest-growing segment. By end user, hospitals and blood banks lead, followed by independent diagnostic laboratories. North America currently holds the largest share, supported by advanced transfusion infrastructure, while Asia-Pacific is the fastest-growing region on the back of healthcare investment in China, India, and Southeast Asia.

• •Serological methods lead volume; molecular/genotyping leads growth rate
• •North America is the largest regional market; Asia-Pacific is the fastest-growing
• •Hospitals and blood banks are the primary end users, with diagnostics labs gaining share

What are the recent trends and outlook?

The most significant trend is the transition from purely serological workflows to hybrid models that combine traditional agglutination testing with PCR-based genotyping for extended antigen matching. Automation, laboratory information system integration, and high-throughput donor typing are reshaping blood-bank operations, while point-of-care and microfluidic platforms are emerging for use in low-resource settings. Over the coming decade, expect stronger growth in molecular kits, software-driven donor-management tools, and Asia-Pacific-led volume expansion.

• •Hybrid serology-plus-genotyping workflows are becoming the new standard in advanced blood banks
• •High-throughput donor typing and LIS-integrated software are gaining traction
• •Point-of-care and microfluidic typing platforms are emerging for decentralized and field use